Story perspectives

Sam Neill Cancer-Free After Experimental CAR-T Therapy for Rare Lymphoma

4/30/2026

Summary

Sam Neill Cancer-Free

Sam Neill announced he is cancer-free after experimental CAR-T cell therapy.
He was diagnosed in 2023 with stage-three angioimmunoblastic T-cell lymphoma after chemotherapy stopped working.
Doctors harvested his T cells, engineered them, and reinfused them to train his immune system to destroy the cancer.
A recent scan showed no detectable cancer, which he called extraordinary, prompting his excitement to return to acting.

Summary

Sam Neill Funding

Sam Neill urges Australian governments, with Snowdome, to fund CAR-T therapy for all blood-cancer patients.
He says treatment is limited to certain public hospitals and can exceed A$600,000 (£320,000, US$430,000) privately.
He cites a 2025 U.S. case where a child treated with CAR-T for neuroblastoma remained cancer-free for 18 years.
He cites FDA-approved uses like acute lymphoblastic leukemia and multiple myeloma to push for broader Australian approval and equity in New Zealand.

1 of 2

Sam Neill Cancer-Free

Sam Neill announced he is cancer-free after experimental CAR-T cell therapy.
He was diagnosed in 2023 with stage-three angioimmunoblastic T-cell lymphoma after chemotherapy stopped working.
Doctors harvested his T cells, engineered them, and reinfused them to train his immune system to destroy the cancer.
A recent scan showed no detectable cancer, which he called extraordinary, prompting his excitement to return to acting.

1 / 2